The future of biobanking: A conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers

Advances in Experimental Medicine and Biology

Volumn 864, Issue , 2015, Pages 11-27

  Somiari, Stella B ^a   Somiari, Richard I ^b  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b ITSI Biosciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BIOBANKING; COMMERCIAL PHENOMENA; COMMUNITY HOSPITAL; FUNDING; GENOMICS; GOVERNMENT; HUMAN; MANUFACTURING INDUSTRY; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; PERSONALIZED MEDICINE; PRESERVATION AND STORAGE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PUBLIC-PRIVATE PARTNERSHIP; QUALITY CONTROL; STANDARDIZATION; UNITED STATES; BIOBANK; PERSONNEL; SPECIMEN HANDLING;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; HUMANS; RESEARCH PERSONNEL; SPECIMEN HANDLING;

EID: 84942882111     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-20579-3_2     Document Type: Chapter

References (30)

1. Slamon DJ, Clark GM, Wng SG, Levin WJ, Ulrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplifi cation of the HER-2/neu oncogene. Science 235:177–182
2. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al (1989) Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244:707–712
3. Ragin C, Park JY (2014) Biospecimen, biobanking and global cancer research collaborations. Ecancermedicalscience 8:454. doi: 10.3332/ ecancer.2014.454
4. Clausen KP, Grizzle WE, LiVolsi V, Newton WA, Aamodt R (1989) The cooperative human tissue network. Cancer 63:1452–1455
5. Hoeyer K (2012) Size matters: the ethical, legal and social issues surrounding large-scale genetic biobank initiatives. Norsk Epidemiol 21:211–220
6. Watson PH, Barnes RO (2011) A proposed schema for classifying human research biobanks. Biopreserv Biobank 9(4):327–333
7. Henderson GE, Cadigan RJ, Edwards TP, Conlon I, Nelson AG, Evans JP, Davis AM, Zimmer C, Weiner BJ (2013) Characterizing biobank organizations in the US: results from a national survey. Genome Med 5:3, http://genomemedicine.com/content/5/1/3
8. Eiseman E, Bloom G, Brower J, Clancy N, Olmstead S (2003) Case study of existing human tissue repositories. RAND, Santa Monica
9. Market Research Report (2011) Pharma and biotech companies increasingly outsource Biobanking Companies and Markets.com (http://www.companiesandmarkets. com/Market/Healthcare-and- Medical/ Market-Research/Biobanks-A-Global-Strategic-Business-Report/RPT1021074References)
10. Ball L, Fisher T (2014) Collaborative models for managing research samples in China. Pharm Outsourcing 15(4):1–3
11. De Souza YG, Greenspan JS (2013) Biobanking past, present and future: responsibilities and benefits. AIDS 27(3):303–312. NIH Public Access. doi: 10.1097/QAD.0b013e32835c1244
12. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfi eld E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J (2011) Biospecimen reporting for improved study quality (BRISQ). J Proteome Res 10(8):3429–3438. doi: 10.1021/pr200021n
13. Mitchell R (2010) National biobanks: clinical labor, risk production, and the creation of biovalues. Sci Technol Human Values 1: 35(3):330–335. NIH Public Access doi: 10.1177/0162243909340267
14. Polašek O (2013) Future of biobanks-bigger, longer, and more dimensional. BIO-OBJECTS Croat Med J 54:496–500. doi: 10.3325/cmj.2013.54.496
15. Herpel E, Koleganova N, Schirmacher P (2008) Tissue bank of the National Center for Tumor Disease: an innovative platform for translational tumor. Pathology 29(Suppl 2):204–209
16. Knox K, Kerr DJ (2004) Establishing a national tissue bank for surgically harvested cancer tissue. Br J Surg 91:134–136
17. LiVolski VA, Clausen KP, Grizzle W, Newton W, Pretlow TG, Aamodt R (1993) The cooperative human tissue network: an update. Cancer 71:1391–1394
18. Riegman PH, Dinjens WN, Oomen MH, Spatz A, Ratcliffe C, Knox K, Mager R, Kerr D, Pezzella F, van Damme B, van de Vijver M, van Boven H, Morente MM, Alonso S, Kerjaschki D, Pammer J, Lopez- Guerrero JA, Llombart Bosch A, Carbone A, Gloghini A, Teodorovic I, Isabelle M, Jaminé D, Passioukov A, Lejeune S, Therasse P, van Veen EB, Lam KH, Oosterhuis JW (2006) TuBaFrost 1: uniting local frozen tumor banks into a European network: an overview. Eur J Cancer 42:2678–2683
19. Stege A, Hummel M (2008) Experience with established and operation of biobank. Pathologe 29(Suppl 2):214–217
20. Von Strauss und Torney M, Güller U, Rezaeian F, Brosi P, Terracciano L, Zuber M (2012) Tissue banking in a regional hospital: a promising future concept? First report on fresh frozen tissue banking in a hospital without an integrated institute of pathology. World J Surg 36:2300–2304
21. Yuille M, van Ommen GJ, Bréchot C, Cambon- Thomsen A, Dagher G, Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, Wichmann HE, Zatloukal K (2008) Biobanking for Europe. Brief Bioinform 9(1):14–24
22. Hewitt R, Hainaut P (2011) Biobanking in a fast moving world: an international perspective. J Natl Cancer Inst Monogr 42:50–51
23. Mayo DN, Woo P, Keck A (2010) Blueprint for the development of a community-based hospital biorepository. Biopreserv Biobank 8(3):139–145
24. Mayo-Heath DN, Woo P, Keck A (2011) Biorepository considerations: a detailed topic follow-up to the blueprint for the development of a community-based hospital biorepository. Biopreserv Biobank 9(4):321–326
25. Greenspan R, O’Donnell A, Meyer J, Kane J, Mamula K, Lubert S, Deyarmin B, Larson C, Rigby S, Greenawalt A, Vatanian N, Mural R, Shriver C, Somiari S (2013) Tissue imprint: assessing their potential for routine biobanking collection. Biopreserv Biobank 11(6):359–365
26. Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 42:24–31
27. Hofman P, Bréchot C, Zatloukal K (2014) Publicprivate relationship in biobanking: a still underestimated key component of open innovation. Virchows Arch 464:3–9
28. Olson JE, Bielinski SJ, Ryu E, Winkler EM, Takshashi PY, Pathak J, Cerhan JR (2014) Biobanks and personalized medicine. Clin Genet 86:50–55
29. Shaw PM, Patterson SD (2011) The value of banked samples for oncology drug discovery and development. J Natl Cancer Inst Monogr 42:46–49
30. Fiore LD, D’Avoli LW (2001) Detours on the road to personalized medicine: barriers to biomarker validation and implementation. JAMA 306:1914–1915